Pfizer : PFE

All Pfizer Articles

1501 Articles

Lee Jackson | Jun 10, 2026 at 7:59 AM EDT

Here Are Wednesday’s Top Wall Street Analyst Research Calls: BILL Holdings, Cava Group, Entergy, GlobalFoundries, Hess Midstream, Nike, Pfizer, SharkNinja, STMicroelectronics, and More

Pre-Market Stock Futures: Futures are trading lower after the stock market tried to take a cue from Monday’s action, and…

Vandita Jadeja | Jun 10, 2026 at 2:06 AM EDT

Prediction: Pfizer Stock Will Double on This Date

Pfizer (NYSE:PFE | PFE Price Prediction) trades at $25.62, pays a 6.7% dividend yield, and just posted five straight quarterly…

Vandita Jadeja | Jun 9, 2026 at 2:53 PM EDT

Earn $5,000+ Yearly With These 4 Dividend Stocks

Earned income has a ceiling. Hours in a day, headcount budgets, layoff cycles, and corporate restructurings all cap how much…

Omor Ibne Ehsan | Jun 8, 2026 at 11:57 AM EDT

Watch Out, Rising Capex Could Turn Today’s Cash Cows Into Dogs

Pacer US Cash Cows 100 ETF (NYSEARCA:COWZ) owns the 100 Russell 1000 names that generate the most free cash flow…

Vandita Jadeja | Jun 3, 2026 at 10:06 AM EDT

Pfizer vs Merck: Chasing High Yield vs Higher Returns

Pfizer (NYSE:PFE | PFE Price Prediction) and Merck (NYSE:MRK) both just closed earnings chapters that frame the 2026 dividend debate…

Vandita Jadeja | Jun 2, 2026 at 10:03 AM EDT

Why Pfizer’s Current Price May Be Too Cheap to Ignore

Pfizer (NYSE:PFE | PFE Price Prediction) is one of those names where the headline narrative (COVID hangover, patent cliff) keeps…

Trey Thoelcke | May 28, 2026 at 10:05 AM EDT

Insiders Aren’t Buying Pfizer Stock at $26 and That’s Actually a Good Thing

The smart money on Pfizer (NYSE: PFE | PFE Price Prediction) is sending a quieter signal than the financial press…

Trey Thoelcke | May 26, 2026 at 8:50 AM EDT

If Viking Therapeutics Is Acquired, Here’s Who Wins

Polymarket traders are watching one biotech more closely than any other for an acquisition. Viking Therapeutics (NASDAQ: VKTX | VKTX…

Michael Williams | May 24, 2026 at 2:00 PM EDT

Why Retirees Keep Buying This Dividend ETF After 22 Years of Payments

iShares Select Dividend ETF (NASDAQ:DVY) is one of the older income-focused funds on the market. The question for owners is…

Alex Sirois | May 19, 2026 at 12:38 PM EDT

The SoFi CEO Just Bought 70,000 Shares With His Own Money. Here Are Four More Under $30 Worth a Closer Look

With markets at elevated multiples in May 2026, low share prices can mislead investors into thinking quality is out of…

David Moadel | May 19, 2026 at 12:15 PM EDT

Citi Initiates BridgeBio at Neutral: Why the Cardiomyopathy Story Isn’t a Slam Dunk

BridgeBio Pharma (NASDAQ:BBIO | BBIO Price Prediction) received a Neutral initiation from Citi Neutral on Tuesday, reflecting a measured stance…

Alex Sirois | May 19, 2026 at 10:46 AM EDT

Rate Cuts Are Off the Table. Here Are 2 Stocks Under $30 Built Exactly for This Moment

With short-term rates still elevated, tariff uncertainty churning through earnings models, and credit spreads widening at the margins, balance sheet…

Austin Smith | May 16, 2026 at 6:00 AM EDT

GRNY Beat COWZ by 11 Points This Year. Oil Prices and Interest Rates Will Decide Who Wins Next

The Pacer US Cash Cows 100 ETF (NYSEARCA:COWZ) and the Fundstrat Granny Shots US Large Cap ETF (NYSEARCA:GRNY) sit on…

Alex Sirois | May 15, 2026 at 9:49 AM EDT

Michael Burry’s Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why

Pfizer (NYSE:PFE | PFE Price Prediction) at $25.75, Molina Healthcare (NYSE:MOH) at $186.80, and Halliburton (NYSE:HAL) at $41.29 trade at…

Alex Sirois | May 12, 2026 at 9:34 AM EDT

3 Berkshire Stocks Under $30 and 2 Under $30 Greg Abel May Buy

Warren Buffett built Berkshire Hathaway by paying reasonable prices for durable cash flows, and three of his current bets still…

1 2 3 4 … 101

Pfizer : PFE

All Pfizer Articles

Here Are Wednesday’s Top Wall Street Analyst Research Calls: BILL Holdings, Cava Group, Entergy, GlobalFoundries, Hess Midstream, Nike, Pfizer, SharkNinja, STMicroelectronics, and More

Prediction: Pfizer Stock Will Double on This Date

Earn $5,000+ Yearly With These 4 Dividend Stocks

Watch Out, Rising Capex Could Turn Today’s Cash Cows Into Dogs

Pfizer vs Merck: Chasing High Yield vs Higher Returns

Why Pfizer’s Current Price May Be Too Cheap to Ignore

Insiders Aren’t Buying Pfizer Stock at $26 and That’s Actually a Good Thing

If Viking Therapeutics Is Acquired, Here’s Who Wins

Why Retirees Keep Buying This Dividend ETF After 22 Years of Payments

The SoFi CEO Just Bought 70,000 Shares With His Own Money. Here Are Four More Under $30 Worth a Closer Look

Citi Initiates BridgeBio at Neutral: Why the Cardiomyopathy Story Isn’t a Slam Dunk

Rate Cuts Are Off the Table. Here Are 2 Stocks Under $30 Built Exactly for This Moment

GRNY Beat COWZ by 11 Points This Year. Oil Prices and Interest Rates Will Decide Who Wins Next

Michael Burry’s Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why

3 Berkshire Stocks Under $30 and 2 Under $30 Greg Abel May Buy

Nasdaq Income Without the Megacap Risk: How JEPQ Caps Your Upside for Monthly Cash

More Than 6 Million Children Have Enrolled in Trump Accounts. Here’s Why They Could Become “Tax-Free Millionaires”

Ex-Nasdaq CEO Warns SpaceX’s ‘Unprecedented’ Lockup Expiration Could Flood the Market With $800 Billion in Shares

More Than 6 Million Children Have Enrolled in Trump Accounts. Here's Why They Could Become "Tax-Free Millionaires"

Are Online Banks Safe? What Happens to Your Money if One Fails

Nasdaq Income Without the Megacap Risk: How JEPQ Caps Your Upside for Monthly Cash

More Than 6 Million Children Have Enrolled in Trump Accounts. Here’s Why They Could Become “Tax-Free Millionaires”

Pfizer : PFE

All Pfizer Articles

Here Are Wednesday’s Top Wall Street Analyst Research Calls: BILL Holdings, Cava Group, Entergy, GlobalFoundries, Hess Midstream, Nike, Pfizer, SharkNinja, STMicroelectronics, and More

Prediction: Pfizer Stock Will Double on This Date

Earn $5,000+ Yearly With These 4 Dividend Stocks

Watch Out, Rising Capex Could Turn Today’s Cash Cows Into Dogs

Pfizer vs Merck: Chasing High Yield vs Higher Returns

Why Pfizer’s Current Price May Be Too Cheap to Ignore

Insiders Aren’t Buying Pfizer Stock at $26 and That’s Actually a Good Thing

If Viking Therapeutics Is Acquired, Here’s Who Wins

Why Retirees Keep Buying This Dividend ETF After 22 Years of Payments

The SoFi CEO Just Bought 70,000 Shares With His Own Money. Here Are Four More Under $30 Worth a Closer Look

Citi Initiates BridgeBio at Neutral: Why the Cardiomyopathy Story Isn’t a Slam Dunk

Rate Cuts Are Off the Table. Here Are 2 Stocks Under $30 Built Exactly for This Moment

GRNY Beat COWZ by 11 Points This Year. Oil Prices and Interest Rates Will Decide Who Wins Next

Michael Burry’s Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why

3 Berkshire Stocks Under $30 and 2 Under $30 Greg Abel May Buy

Nasdaq Income Without the Megacap Risk: How JEPQ Caps Your Upside for Monthly Cash

More Than 6 Million Children Have Enrolled in Trump Accounts. Here’s Why They Could Become “Tax-Free Millionaires”

Ex-Nasdaq CEO Warns SpaceX’s ‘Unprecedented’ Lockup Expiration Could Flood the Market With $800 Billion in Shares

Featured Reads

More Than 6 Million Children Have Enrolled in Trump Accounts. Here's Why They Could Become "Tax-Free Millionaires"

Are Online Banks Safe? What Happens to Your Money if One Fails